oncology

Showing 15 posts of 328 posts found.

Caner image

More cancer patients surviving for longer

October 31, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …

Celgene image

Celgene expands immunotherapy pipeline with Sutro

October 27, 2014
Research and Development, Sales and Marketing Celgene, PD-1 and PD-L1, Q3, oncology, sutro

Celgene has extended its collaboration with Sutro Biopharma and added a buyout option for the firm as the two companies …

AZ image

AZ oncology drug a ‘Phoenix from the flames’

October 27, 2014
Sales and Marketing AstraZeneca, CHMP, EC, lynparza, olaparib, oncology

As the possibility of a deal with Pfizer fades, AstraZeneca is continuing its argument for independence as a key cancer …

prof_paul_workman

Cancer drug discovery system ‘broken’

October 24, 2014
Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman

The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new …

Reverse the odds image

Charity launches second cancer research game

October 9, 2014
Medical Communications, Sales and Marketing CRUK, Cancer, amazon, genes in space, oncology, play, reverse the odds

Cancer Research UK has launched its second citizen science game this year called ‘Reverse The Odds’ in an attempt to …

Novartis image

Novartis says three executives departing firm

October 9, 2014
Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines

Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …

NHS England consults on Cancer Drugs Fund

October 6, 2014
Research and Development, Sales and Marketing CDF, Cancer, NHS, NHS England, commissioning, oncology

NHS England is declaring new changes to the way the Cancer Drugs Fund operates in order to plug a major …

Roche image

Roche falls foul of NICE rules, again

October 3, 2014
Medical Communications, Sales and Marketing CLL, Gazyvaro, NICE, Roche, blood cancer, oncology

Uncertainties in the data and high cost have seen NICE make an initial rejection of Roche’s new blood cancer drug …

Cancer cells image

Half of cancers diagnosed at late stage

September 22, 2014
Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, oncology

A Cancer Research UK study out today reveals that nearly half of all cancers in England are diagnosed at an …

Zydelig image

Gilead’s blood cancer pill approved in Europe

September 22, 2014
Sales and Marketing CLL, Gilead, blood cancer, fl, idelalisib, oncology, zydelig

Gilead has gained European Commission approval for its new blood cancer pill Zydelig (idelalisib) as it looks to expand further …

boehringer_angle_22

Boehringer pays $600m for cancer vaccine deal

September 19, 2014
Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1

Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …

Cancer drug gains first early UK access grant

September 17, 2014
Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising

A new type of cell therapy for cancer has become the first to be deemed by the UK government as …

NHS image

NHS cancer services not holding up, says report

September 8, 2014
Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology

NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …

Medimmune image

MedImmune to work with biotech Advaxis on cancer

July 22, 2014
Research and Development, Sales and Marketing Advaxis, AstraZeneca, Cancer, MEDI4736, MedImmune, oncology, pd1

AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …

Genentech image

Genentech to buy Seragon

July 3, 2014
Sales and Marketing Genentech, Roche, breast cancer, oncology, serds

Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …

The Gateway to Local Adoption Series

Latest content